The word "nootropic" is on the front of hundreds of UK supplement bottles in April 2026. It is also, somewhat awkwardly, the subject of a growing body of advertising regulatory rulings which have effectively made it legally hazardous for the brands using it. This guide explains what a nootropic is, what the research actually shows, how to read a supplement label without being misled, and what the UK regulator has decided about the word's use in marketing.

If you take nothing else from this guide, take this: the nootropic category is wider and less evidence-supported than most brand marketing implies. Some individual ingredients have meaningful human trial support. Most branded multi-ingredient stacks do not. The gap between what is marketed and what is demonstrated is unusually large even by supplement-industry standards.

Where the word came from.

The word "nootropic" was coined in 1972 by Romanian chemist Corneliu Giurgea, who had synthesised piracetam — one of the first compounds in what would become the "racetam" family of cognitive pharmaceuticals. Giurgea proposed five specific criteria that a compound had to meet to qualify as a true nootropic: it should enhance learning and memory, protect the brain against injury, enhance cortical control mechanisms, have minimal side effects, and demonstrate neuroprotective properties. The word is built from the Greek nous (mind) and trepein (to bend) — literally, "mind-bending," though in the neutral rather than recreational sense.

In its original pharmacological sense, "nootropic" described a narrow category of specific compounds. Over the intervening five decades the word has broadened dramatically. The modern supplement industry uses "nootropic" to describe roughly anything ingested for cognitive purposes — caffeine, fish oil, vitamin B12, single-ingredient botanicals, elaborate multi-ingredient capsule stacks. Some of these products would meet Giurgea's original five criteria; most would not. The word's meaning has expanded until it points at almost everything and therefore, arguably, at nothing in particular.

This expansion matters for buyers because the marketing evokes the original pharmacological heft while often delivering something much more modest — a blend of B-vitamins, a small dose of rhodiola, perhaps some bacopa. The bottle says "nootropic" and the reader's associations do the rest of the marketing work.

How the UK regulator sees it.

The Advertising Standards Authority (ASA), working with the Committee of Advertising Practice (CAP) Code, regulates nutrition and health claims in UK advertising. Supplements are classified as food rather than medicine under UK law, which means they fall under Section 15 of the CAP Code — a framework that only permits health claims which appear on the GB Nutrition and Health Claims Register with authorisation.

In a series of rulings beginning in 2024, the ASA made its position on the word "nootropic" explicit. When a brand markets a product as a "nootropic," the ASA ruled, consumers familiar with the term understand it to mean that the product enhances cognitive function and mental performance. That understanding makes the word itself a specific health claim, which means the brand can only use it if the specific product and its ingredients hold authorised claims on the GB Register relating to cognitive function.

Here is the problem for the industry: almost no branded nootropic formulation holds such claims. The GB Register includes authorised claims for certain B-vitamins ("contributes to normal psychological function"), iron ("contributes to normal cognitive function"), zinc, magnesium, and a handful of others — but these are vitamin-and-mineral claims, not claims for specific branded blends or botanical ingredients. The bacopa in your nootropic stack does not hold an authorised GB Register claim. Neither does the lion's mane, the rhodiola, the phosphatidylserine, or the citicoline.

The ASA has effectively ruled that the word "nootropic" is too strong for what the underlying evidence on most branded stacks supports. UK brands can sell the products; they are increasingly constrained in what they can say about them.

The ASA has upheld specific rulings against multiple nootropic brands in the 2024-2026 period, including Feel Güd (Nowt Ventures), Auri Nutrition (Ejec Ventures), Well Gummies, Innocent Health, Hangcure, Get Dopa, and several others. These rulings typically cover three separate breaches: unauthorised specific health claims, unauthorised general health claims, and (in some cases) marketing of unauthorised novel food ingredients.

What the evidence actually shows.

Different nootropic ingredients have different evidence bases. Some have strong, consistent human trial support. Others have animal studies but little human data. A few have essentially no evidence at all. Here is an honest assessment of the main compounds you'll see on UK supplement labels, graded by strength of human trial evidence:

One genuinely honest observation worth sitting with: the two ingredients with the strongest evidence in this category are caffeine and L-theanine. You can buy them together for around £15 a month from any reputable single-ingredient supplier. A branded nootropic stack at £65 a month is, in evidence terms, largely repackaging this base with a handful of weaker-evidence ingredients added on top. Whether that additional complexity is worth the price difference depends entirely on your priorities — but the buyer should know the trade-off they are making.

How to read a nootropic label.

Most nootropic buyers never read the supplement facts panel with any care. It is, however, the single most useful skill you can develop for this category. A well-formulated product and a poorly-formulated one often look identical from the front of the packaging. The differences are all on the back.

1. Does it list exact doses, or hide them in a proprietary blend?

Proprietary blends list the total weight of a group of ingredients without breaking out the individual doses. "Proprietary Cognitive Matrix: 800mg" tells you nothing about how much of each compound is actually in the capsule. This is almost always a sign of underdosing — brands use proprietary blends specifically so they can include expensive-sounding ingredients at cosmetic doses without revealing it. If you see a proprietary blend, assume the best-marketed ingredient is present at the lowest effective dose or below.

2. Do the doses match the research literature?

For each ingredient you recognise, check whether the dose is within the range of what the underlying trials used. Bacopa is commonly researched at 300mg of 24-55% bacoside extract; a bottle with 50mg of unspecified extract is a cosmetic dose. Rhodiola trials often use 200-400mg; 50mg is sub-therapeutic. Citicoline research uses 250-500mg; anything less is largely symbolic. If the doses are below research levels, you are buying the marketing rather than the formulation.

3. Is the extract form specified?

For botanical ingredients, the extract form and standardisation matter enormously. "Bacopa monnieri 300mg" is less useful than "Bacopa monnieri 300mg (24% bacosides)." Without knowing what's been extracted, the 300mg figure is not meaningfully comparable to the trial literature. Premium formulations specify extract percentages; lower-quality formulations don't.

4. Is there a disclosed caffeine content?

Many "nootropic" products are effectively caffeine delivered with supplement dressing. If the product contains caffeine, the amount should be on the label. 50-100mg is a sensible functional dose; 200mg+ is effectively a strong coffee with a multi-vitamin layered over it. Some brands obscure caffeine by listing it under an ingredient like guarana extract — check for this.

5. Who makes it, and where?

UK-based manufacturers operating under GMP certification are preferable for quality assurance. Brands based in the UK are also subject to UK advertising and food law, which means consumer protection applies more cleanly than for imports. Check the brand's registered address on their website footer; if you can't find one, that tells you something.

What to avoid.

• Proprietary blends without ingredient breakdown. The single biggest red flag in the category. Brands use these to hide underdosing.
• Promises of "limitless" effects or dramatic transformation. Inconsistent with the underlying evidence; often indicates marketing outpacing formulation.
• Claims that the product cures anxiety, ADHD, depression, or other conditions. These are medicinal claims and banned under the CAP Code. Brands making them are willing to ignore UK regulation, which tells you what you need to know about their formulation standards.
• Turkey tail mushroom (trametes versicolor) in UK-sold products. Classified by the FSA as an unauthorised novel food; products containing it are technically illegal to sell in the UK.
• Unstandardised botanical extracts. Without an extract percentage, the dose figure is meaningless.
• Celebrity endorsements or influencer-driven launches. Not automatically disqualifying, but common correlate of thin formulations and marketing-led businesses.
• Aggressive subscription tactics with difficult cancellation. A signal about the brand's broader relationship to its customers.
• Prescription-only compounds offered without a prescription. Modafinil is prescription-only in the UK for a reason; online sellers offering it are either breaking the law or selling something else.

Are they safe?

Individual ingredient safety varies. The caffeine-and-L-theanine stack at normal doses has an extensive safety record. Creatine is one of the most-studied supplements in existence and carries a strong safety profile. Bacopa, lion's mane, and citicoline at standard doses are generally well-tolerated.

The significant concern is interactions with prescription medication. Many nootropic ingredients — particularly bacopa, rhodiola, and some mushroom extracts — interact with medications processed through the CYP450 enzyme system, which includes SSRIs, blood thinners, and many other common prescriptions. Before starting any nootropic stack, speak to your GP or pharmacist, particularly if you take regular medication.

Specific groups should not take nootropic stacks without medical advice: anyone under 18, pregnant or breastfeeding women, people with diagnosed neurological conditions, and people being treated for mood disorders. The evidence base for these populations is thin or contraindicating, and the potential for interaction is high.

A sensible approach, in one paragraph.

If you want to try the nootropic category, start with the ingredients with the strongest evidence — caffeine and L-theanine, and perhaps creatine — at researched doses from reputable single-ingredient suppliers. You'll spend around £15 per month. Give this base protocol a full month of consistent use and notice what, if anything, changes. If you want to explore further, consider a branded stack with published ingredient doses and (where possible) some evidence for the formulation itself — our buying guide covers the UK options. Do not expect dramatic effects; the underlying ingredient literature does not support them. And never combine any nootropic with prescription medication without speaking to your GP.

Frequently asked questions.

Is "nootropic" a regulated term?

In UK advertising law, the word itself is treated as a specific health claim by the Advertising Standards Authority. Brands can use it only alongside authorised claims on the GB Nutrition and Health Claims Register. Outside of advertising, the word is not formally regulated — anyone can sell "a nootropic supplement" as long as the claims they make about it are compliant.

What's the difference between a nootropic and an adaptogen?

The categories overlap but have different traditional emphases. Nootropics are associated with cognitive performance (focus, memory). Adaptogens are associated with stress response (calm, resilience). Many ingredients sit in both categories — ashwagandha, rhodiola, and lion's mane all appear in both nootropic stacks and adaptogen products. The ASA treats both words as specific health claims.

Can I take nootropics with coffee?

If the nootropic product already contains caffeine (many do), adding more from coffee can push you into uncomfortable stimulation territory. If the product is explicitly stimulant-free (Mind Lab Pro, for instance), combining with coffee is generally fine for most people. L-theanine plus caffeine is a well-established stack that many brands package specifically.

What about prescription nootropics like modafinil?

Modafinil is a wakefulness-promoting medication prescribed in the UK for narcolepsy, shift work sleep disorder, and similar indications. It is Schedule IV and prescription-only. Obtaining it without a prescription is not legal in the UK and we do not cover prescription-only compounds on The Calmer List. If you think you might benefit from modafinil, speak to your GP.

Can children or teenagers take nootropic supplements?

No. The evidence base for nootropic supplements in under-18s is thin or non-existent, and developing brains respond differently to adult ones. Do not give nootropic stacks to anyone under 18 without explicit medical advice.

How quickly should I expect to feel effects?

Caffeine effects are felt within 30 minutes. Most other nootropic ingredients — bacopa, lion's mane, phosphatidylserine, citicoline — require sustained use over several weeks before any subjective effects might register. If you buy a stimulant-free stack expecting to feel something on day one, you will likely be disappointed; that isn't how these ingredients work in the underlying literature.

Is the entourage effect real for nootropics?

The "entourage effect" is a term from the cannabis literature that has been borrowed by some nootropic marketers to argue multi-ingredient stacks work better than single ingredients. For nootropic ingredients specifically, the evidence for synergistic effects is thinner than marketing implies. Well-combined stacks may be more convenient than multiple single-ingredient supplements, but the assumption that combining multiple botanicals produces a "greater than sum of parts" effect is not consistently supported.

Further reading.

• GB Nutrition and Health Claims Register — the official list of authorised health claims for food and supplements in Great Britain.
• ASA Supplements Guidance — asa.org.uk/advice-online/food-supplements
• CAP Code Section 15 — the rules for food, food supplements, and health claims in UK advertising
• Examine.com — an independent, non-commercial database of human trial evidence on individual supplement ingredients. The best single source for verifying research claims.